Tsukagoshi H, Aoki S, Kurosawa M
First Department of Internal Medicine, Gunma University School of Medicine, Maebashi, Japan.
Nihon Kyobu Shikkan Gakkai Zasshi. 1990 Nov;28(11):1450-5.
Platelet activating factor (PAF) has recently been demonstrated to play an important role in allergic diseases such as bronchial asthma. Changes in airway wall thickness have recently been suggested to cause excess airway narrowing of asthma. In this study, the authors examined the bronchial hyperresponsiveness to histamine in guinea pig induced by intravenous administration of PAF by measuring dynamic compliance and dynamic respiratory resistance. Moreover, a new formula which can exclude the effect of the changes of the airway wall thickness was proposed. With this formula, the administration of PAF was suggested to induce airway wall to be thickened. The ratio of bronchial smooth muscle constriction by histamine was significantly enhanced by the administration of PAF (p less than 0.05). Moreover, antagonists such as CV3988 and CV6209 inhibited the effect of PAF. The above results suggest that PAF may be an important mediator affecting bronchial hyperresponsiveness.
血小板活化因子(PAF)最近被证明在诸如支气管哮喘等过敏性疾病中起重要作用。最近有人提出气道壁厚度的变化会导致哮喘患者气道过度狭窄。在本研究中,作者通过测量动态顺应性和动态呼吸阻力,研究了静脉注射PAF诱导的豚鼠对组胺的支气管高反应性。此外,还提出了一种可以排除气道壁厚度变化影响的新公式。根据该公式,提示PAF的给药会导致气道壁增厚。PAF给药显著增强了组胺引起的支气管平滑肌收缩比例(p小于0.05)。此外,CV3988和CV6209等拮抗剂可抑制PAF的作用。上述结果表明,PAF可能是影响支气管高反应性的重要介质。